Table 2 Details of the intravenous therapy for the neonate participants
Variables | Control Group (n = 104) F (%) | Intervention Group (n = 109) F (%) | p-value for difference |
|---|---|---|---|
Peripheral IV device for continuous infusion. | 53 (50.96) | 52 (47.71) | 0.64‡ |
Peripheral IV device with vesicant administration. | 11 (10.58) | 17 (15.60) | 0.28‡ |
Number of peripheral IV catheter in-situ. | Mean (SD) 2.88 (2.85) | Mean (SD) 2.86 (2.96) | 0.96# |
Peripheral IV catheter days. | Mean (SD) 8.22 (8.76) | Mean (SD) 9.48 (8.79) | 0.30# |
Number of patients with CVC. | 26 (25%) | 31 (28.44%) | 0.40‡ |
Number of CVC in-situ. | Mean (SD) 1.58 (0.50) | Mean (SD) 1.45 (0.51) | 0.36# |
CVC days. | Mean (SD) 15.58 (8.41) | Mean (SD) 14.23 (6.97) | 0.51# |